Forma Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on August 13, 2021
August 06 2021 - 7:05AM
Business Wire
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a
clinical-stage biopharmaceutical company focused on rare
hematologic diseases and cancers, today announced that it will
release second quarter 2021 financial results Friday, Aug. 13,
2021. Forma management will host an investment community conference
call at 8 a.m. Eastern Time, on Aug. 13, 2021, to discuss these
financial results and provide a business update.
Investors may participate by dialing +1 (833) 301-1146 in the
U.S. or Canada, or +1 (914) 987-7386 internationally, and by
referring to Conference ID 9155938. A live webcast of the
conference call will be available in the “News & Investors”
section of Forma’s website at www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company
focused on the research, development and commercialization of novel
therapeutics to transform the lives of patients with rare
hematologic diseases and cancers. Our R&D engine combines deep
biology insight, chemistry expertise and clinical development
capabilities to create drug candidates with differentiated
mechanisms of action focused on indications with high unmet need.
Our work has generated a broad proprietary portfolio of programs
with the potential to provide profound patient benefit. For more
information, please visit www.FormaTherapeutics.com or follow us on
Twitter @FORMAInc and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210806005026/en/
Investor Contact: Mario Corso, +1 781-366-5726 Forma
Therapeutics, Inc. mcorso@formatherapeutics.com
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Oct 2023 to Oct 2024